New Partnership to Develop State-of-the-Art Research Program and Platform to Detect, Treat and Prevent the Spread of AMR Infectious Disease

Governor Cuomo today announced a groundbreaking partnership between ILÚM Health Solutions, a wholly-owned subsidiary of Merck & Co, OpGen, and the New York State Department of Health to develop a state-of-the-art research program to detect, track and manage antimicrobial-resistant infections at healthcare institutions statewide. ILÚM will partner with the Wadsworth Center and DOH to develop an Infectious Disease Digital Health & Precision Medicine Platform, connecting healthcare institutions to DOH to better track and prevent the spread of infectious disease.

“By investing in public health institutions and innovative research, we are working to protect New Yorkers against harmful infectious diseases while cementing our status as a leader in the growing life sciences sector” Governor Cuomo said. “This groundbreaking partnership will create new, cutting-edge tools to bring life-changing discoveries out of the lab and into the world, moving our economy forward and creating a stronger, healthier New York for all.”

Source: New York State

Effective Surveillance  

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed